YIH
IPSC icon

Y-Intercept (HK)’s Century Therapeutics IPSC Stock Holding History

Y-Intercept (HK)’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-89,975
Closed -$50.3K – 1789
2025
Q2 		$50.3K Buy
+89,975
New +$48.3K ﹤0.01% 1558

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Y-Intercept (HK)'s IPSC Position: Q3 2025 in Review

Y-Intercept (HK) sold out of Century Therapeutics (IPSC) in Q3 2025, closing a stake of 89,975 shares — an estimated $50.3K sold.

Y-Intercept (HK) first reported a position in IPSC in Q2 2025 and held it in 1 quarter. The position peaked at $50.3K in Q2 2025. 57 funds tracked by Wall St. Rank hold IPSC as of Q3 2025.

  • Y-Intercept (HK) reported no remaining Century Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 89,975 Century Therapeutics shares in Q3 2025, an estimated $50.3K.
  • Y-Intercept (HK) first reported a position in Century Therapeutics in Q2 2025 and held it in 1 quarter.
  • Y-Intercept (HK)'s Century Therapeutics position peaked at $50.3K in Q2 2025.
  • 57 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2025.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.